Drug Type Small molecule drug |
Synonyms Paraldehyde (USP), Paral |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (31 Aug 2009), |
Regulation- |
Molecular FormulaC6H12O3 |
InChIKeySQYNKIJPMDEDEG-UHFFFAOYSA-N |
CAS Registry123-63-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00705 | Paraldehyde |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Agitation | Australia | 31 Aug 2009 | |
| Alcohol Withdrawal Delirium | Australia | 31 Aug 2009 | |
| Anxiety Disorders | Australia | 31 Aug 2009 | |
| Sedation | Australia | 31 Aug 2009 | |
| Seizures | Australia | 31 Aug 2009 | |
| Epilepsy | - | - | - |
| Sleep Initiation and Maintenance Disorders | - | - | - |





